涉及Chia的四個小規模臨床試驗，三個有效

Table 2: Human clinical trials of chia seed.

Duration Mode of trial Formulation Results Ref. 7 weeks 10 postmenopausal women 25 g chia seed/day Polyunsaturated fatty acid content particularly ALA, and eicosapentaenoic acid (EPA) was elevated after supplementation with milled chia. The result was in agreement with previous studies conducted in hens, rats, and rabbits. [18] 12 weeks Single blinded with 76 subjects (placebo 37; chia seed 39) 25 g chia seed in 250 mL water twice/day Although Nieman et al. have hypothesized that the high dietary fiber and ALA content in chia can promote human weight loss and reduce disease risk factors related to heart disease and obesity, no significant results on weight loss and disease risk factors even though the plasma level of ALA increased. [19] 2 months Randomized trial, with control diet (500 kcal for 2 weeks), 67 metabolic syndrome subjects (placebo 35; beverage 32) Beverage of 235 kcal that contains soy protein, nopal, chia seed, and oat Body weight loss and reduction of triglyceride and blood glucose levels. [20] 120 minutes Randomized, double-blind trial on 11 healthy subjects 50 g white bread containing either 0, 7, 15, or 24 g of chia seed Reduced postprandial glycemia. [21]